Can CSL shares bounce back? 3 experts share their views after brutal 36% sell-off

Investors in CSL Ltd (ASX: CSL) have endured a tough year so far in 2025.

In August, shares in the healthcare titan tumbled by more than 21% after the company released its FY25 results.

In particular, an underperformance in its core plasma therapies business known as…